Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

MicroPort Said to Raise $198 Million in Hong Kong IPO

MicroPort Scientific Corp., which makes equipment for keyhole surgery, raised about HK$1.54 billion ($198.3 million) selling shares at the top of its price range in an initial public offering in Hong Kong, according to two people with knowledge of the transaction.

The Shanghai-based producer of coronary stents sold 252.7 million shares at HK$6.10 apiece, said the people, who declined to be identified because the information was private. Terms for the sale earlier showed that MicroPort had planned to sell shares at HK$4.60 to HK$6.10.

Credit Suisse Group AG and Piper Jaffray Asia Securities managed the sale, according to the company’s IPO prospectus. MicroPort plans to start trading on Sept. 24 under ticker number 853, the prospectus said. Adam Harper, a Hong Kong-based Credit Suisse spokesman, declined to comment. Alex Ko, chief executive officer of Piper Jaffray Asia Holdings Ltd., was not available to comment.

Proceeds of the IPO will be used to develop new products, acquire businesses and expand the company’s production facilities, the prospectus said. The company has an option to sell an additional 37.9 million shares after the listing, the prospectus said.

MicroPort makes so-called interventional and minimally invasive devices to treat vascular diseases. The company supplies more than 1,100 hospitals across China, according to its website.

Chairman Chang Zhaohua, who founded the company in 1998, said on Sept. 12 that MicroPort had overcome doubts about medical devices made in China to acquire a 28.9 percent share of the country’s market for heart stents.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.